Form 4 for RMD ResMed|
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-18 · accession 0001127602-25-020653 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-19 | 2025-08-18 | RMD | Hernandez John | Dir | S - Sale+OE | $287.10 | -2,575 | 4,045 | -39% | -$739.3K |
| D | 2025-08-19 | 2025-08-18 | RMD | Hernandez John | Dir | M - OptEx | $148.90 | +2,575 | 6,620 | +64% | +$383.4K |
| D | 2025-08-19 | 2025-08-18 | RMD | Hernandez John | Dir | M - OptEx | $0.00 | -2,575 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2025-08-18 | S | D | 2,575 | $287.10 | 4,045 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $286.90 - $287.24. The price reported above reflects the weighted average sale price. |
| 2 | Common | ResMed Common Stock | 2025-08-18 | M | A | 2,575 | $148.90 | 6,620 | D | — | — | |
| 3 | Derivative | ResMed Common Stock Options | 2025-08-18 | M | D | 2,575 | $0.00 | 0 | D | $148.90 · 2024-11-11 to 2030-11-16 | 2,575 ResMed Common Stock | (F2) Represents the date options become exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date. |